10 Oct 2025 | 5 Mins Read
Domestic pharma stocks surge up to 5% on US Senate bill passage
Flipitmoney
The US Senate passed the NDAA with 77 votes in favour and 20 against. The NDAA includes the amended Biosecure Act, prohibiting US federal funding and contracts with "biotechnology companies of concern," likely affecting Chinese biotech companies. Shares of Indian pharma companies Divi's Labs, Syngene, Laurus Labs, Piramal Pharma, and Blue Jet Healthcare surged up to 5% on the news.